Cormorant Asset Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Cormorant Asset Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-19,316	Closed	-$278K	–	111
2021 Q2	$278K	Sell	19,316 -114,015	-86%	-$572K	0.01%	102
2021 Q1	$563K	Hold	133,331	–	–	0.01%	117
2020 Q4	$753K	Buy	+133,331	New	+$538K	0.02%	101

Cormorant Asset Management's CEREW Position: Q3 2021 in Review

Cormorant Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 19,316 shares — an estimated $278K sold.

Cormorant Asset Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $753K in Q4 2020. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Cormorant Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Cormorant Asset Management sold 19,316 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $278K.
Cormorant Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Cormorant Asset Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $753K in Q4 2020.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Cormorant Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.